InvestorsHub Logo
Followers 133
Posts 22114
Boards Moderated 0
Alias Born 06/13/2011

Re: None

Friday, 07/12/2024 10:16:40 AM

Friday, July 12, 2024 10:16:40 AM

Post# of 435906
https://www.ipupdate.com/2024/07/is-pleading-generic-enough-to-plead-inducement/

I'm assuming you've all seen this ?

So the key pt ...other than active inducement

” After Hikma’s ANDA was approved, Hikma issued a series of press releases that referred to its product as a “generic” version of Vascepa, even though the product was not approved for the cardiovascular risk indication.



So risk is only to those generics that refer to their product as ...a generic version of Vascepa ?
Kiwi
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News